Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 3/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | THPO | P40225 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.39 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17536630 | 0.91 | FFAR1 (0.39) | GRM5NPC1RAB9ASMN1; SMN2KDM4E | |
| SCHEMBL17536636 | 0.90 | APP (0.48) | GRM5NPC1RAB9ASMN1; SMN2KDM4E | |
| SCHEMBL17552563 | 0.88 | GRM5 (0.50) | GRM5NPC1RAB9ASMN1; SMN2TP53 | |
| SCHEMBL6365168 | 0.85 | APP (0.48) | GRM5NPC1RAB9ASMN1; SMN2KDM4E | |
| SCHEMBL17552564 | 0.78 | ALDH1A1 (0.42) | GRM5NPC1RAB9ASMN1; SMN2KDM4E | |
| SCHEMBL17536620 | 0.78 | GRM5 (0.47) | GRM5CYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL17552568 | 0.78 | CYP2A6 (0.44) | GRM5NPC1RAB9ASMN1; SMN2KDM4E | |
| SCHEMBL3947297 | 0.78 | ESR1 (0.42) | GRM5NPC1RAB9ASMN1; SMN2KDM4E | |
| SCHEMBL23867871 | 0.78 | APP (0.50) | GRM5NPC1RAB9ASMN1; SMN2KDM4E | |
| SCHEMBL17552567 | 0.77 | GRM5 (0.37) | GRM5NPC1RAB9ASMN1; SMN2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3189063-B1 | BASE-CATALYZED SILYLATION OF TERMINIAL ALKYNE C-H BONDS | CALIFORNIA INST OF TECHN (US) | 2019-08-14 | — | — | EP | disclosed |
| US-10072030-B2 | Base-catalyzed silylation of terminal alkyne C—H bonds | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2018-09-11 | — | — | US | disclosed |
| EP-3189063-A1 | BASE-CATALYZED SILYLATION OF TERMINIAL ALKYNE C-H BONDS | California Institute of Technology (US) | 2017-07-12 | — | — | EP | disclosed |
| US-20170088563-A1 | BASE-CATALYZED SILYLATION OF TERMINAL ALKYNE C-H BONDS | NATIONAL SCIENCE FOUNDATION | 2017-03-30 | — | — | US | disclosed |
| US-20170088563-A1 | BASE-CATALYZED SILYLATION OF TERMINAL ALKYNE C-H BONDS | NATIONAL SCIENCE FOUNDATION | 2017-03-30 | — | — | US | disclosed |
| US-9556206-B2 | Base-catalyzed silylation of terminal alkyne C—H bonds | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2017-01-31 | — | — | US | disclosed |
| US-9556206-B2 | Base-catalyzed silylation of terminal alkyne C—H bonds | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2017-01-31 | — | — | US | disclosed |
| WO-2016036685-A1 | BASE-CATALYZED SILYLATION OF TERMINIAL ALKYNE C-H BONDS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2016-03-10 | — | — | WO | disclosed |
| WO-2016036685-A1 | BASE-CATALYZED SILYLATION OF TERMINIAL ALKYNE C-H BONDS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2016-03-10 | — | — | WO | disclosed |
| US-20160060278-A1 | BASE-CATALYZED SILYLATION OF TERMINAL ALKYNE C-H BONDS | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2016-03-03 | — | — | US | disclosed |
| US-20160060278-A1 | BASE-CATALYZED SILYLATION OF TERMINAL ALKYNE C-H BONDS | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2016-03-03 | — | — | US | disclosed |
| US-20160060278-A1 | BASE-CATALYZED SILYLATION OF TERMINAL ALKYNE C-H BONDS | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2016-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160060278-A1 | BASE-CATALYZED SILYLATION OF TERMINAL ALKYNE C-H BONDS | ALKBH3, CA3, ALKBH2 | GRM5 3797/4885NPC1 1295/4885RAB9A 3540/4885 |
| US-20170088563-A1 | BASE-CATALYZED SILYLATION OF TERMINAL ALKYNE C-H BONDS | ALKBH3, CA3, ALKBH2 | GRM5 4034/4885NPC1 1349/4885RAB9A 3558/4885 |
| US-10072030-B2 | Base-catalyzed silylation of terminal alkyne C—H bonds | ALKBH3, CA3, ALKBH2 | GRM5 4027/4885NPC1 1351/4885RAB9A 3522/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.